Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Palifermin (Kepivance) - Important Safety Information from Biovitrum as approved by the Irish Medicines Board

19 April 2010

Important Safety Information communication from Biovitrum on the restriction of the therapeutic indication of Palifermin (Kepivance) and consequential changes to product information.

Important Safety Information - Palifermin (Kepivance)





Date Printed: 26 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971